Capital Allocators – Inside the Institutional Investment Industry

My friend Brian Portnoy recently put together a Zoom call where he and Jonathan Novy interviewed Annie Duke about decision making in the crisis.

Brian was a long-time fund investor and has authored two books in the field of behavioral finance. He and I discussed his second book, The Geometry of Wealth, on Episode 57 that follows on the feed. He is currently a financial wellness consultant for advisors, corporations, and industry associations.

Jonathan is a financial advisor at Ritholtz Wealth Management, a prominent and fast-growing RIA.

And Annie is a regular on the show. She’s a poker legend, decision-making theorist and best selling author. And, she’s releasing a new book later this year entitled How To Decide, but that’s subject matter for another show down the road

What follows is the segment of their call pertaining to the crisis. They discuss the difference between complicated and complex decisions, the tradeoff between time and certainty when making decisions, the process of preparing clients to make good investment decisions today, and decision-making education for children.

Please enjoy Brian and Jonathan’s conversation with Annie Duke.

Learn More Read the Transcript Subscribe to the Capital Allocators Blog or Monthly Mailing List Don't Subscribe, but Let Us Know Who You Are Write a review on iTunes Follow Ted on twitter at @tseides Review past episodes of the Podcast

Gregg Lemkau is the CEO of MSD Partners, the investment firm with roots as Michael Dell's family office. MSD was formed in 1998 to manage $400 million of Michael's capital. In the ensuing twenty-five years, that initial $400 million has grown to north of $20 billion. Gregg joined MSD two years ago after a twenty-eight-year career at Goldman Sachs, where he rose to Co-Head of Investment Banking, served on the Firm's Management Committee, and was widely considered one of a few candidates to succeed David Solomon as Goldman's CEO. Our conversation covers Gregg's career path at Goldman and lessons learned, including entertaining stories about his work with such fascinating entrepreneurs as Elon Musk and Travis Kalanick. We discuss his decision to join MSD, the firm's history, objectives, competitive advantages, and investment capabilities. We then turn to MSD's recently announced merger with BDT Partners, including the rationale, process, and integration of the businesses. We close with a look into the future of the transformed organization. Access Stream by AlphaSense Free Trial

For full show notes, visit the episode webpage here.

Today’s show is a little different from my ongoing series of conversations with Capital Allocators. As you probably know, about 91⁄2 years ago I made a bet with a certain Oracle, in Omaha, that pitted the performance of a group of five hedge fund of funds against the S&P 500. In this year’s annual letter to Berkshire Hathaway shareholders, Warren wrote extensively about his views. You can find that letter at www.berkshirehathway.com/letters. Now I haven’t said a lot about the bet, although fairly often I’m asked how it came about, why I made the bet, what I really think about hedge funds and the market, and of course, who's winning. I thought long and hard about whether to share my views publicly, and had been leaning towards staying out of the limelight. But my guest on Episode 2 of this podcast, André Perold, convinced me that I should share the many other investment lessons the public can learn from this exercise. I thought a podcast would be a perfect venue to discuss my thoughts, so I asked my friend Patrick O’Shaughnessy to discuss the bet with me, and that conversation follows. Before we dive in, I thought it might help to let you know where to find answers to some of those common questions I’m asked. For starters, Carol Loomis, the legendary and recently retired Fortune columnist, wrote a wonderful piece called “Buffett’s Big Bet” back in 2008 that described in detail how the bet came to pass. You can find her piece at www.capitalallocatorspodcast.com/bet. On that same page, you can find links to some of my written thoughts – both at the time of the bet’s inception and two years ago. Next week, I’ll add another link with some concluding thoughts.

For more episodes go to CapitalAllocatorsPodcast.com/Podcast

Follow Ted on twitter at @tseides

Next week, we’ll release the first episode of Season 3 of Private Equity Deals, this time focusing on deals in the middle market. As an interlude between Season 2 and 3, this week’s show is a classic – it’s Bain Capital and KKR’s take private of Hospital Corporation of America (HCA) in 2006. The $33 billion club deal was the largest private equity transaction in history at the time and was significantly larger than any deal since KKR’s famous run at RJR Nabisco in the late 1980s. The HCA deal showed the private equity industry the scale of what was possible and set the stage for both mega buyouts and public to private deals ever since. My guest is Chris Gordon, a Partner and Co-Head of Private Equity in North America for Bain Capital. Bain Capital today is one of the world’s largest private, multi-asset investing firms that oversees over $165 billion in assets. Seventeen years ago, Chris was a younger member of Bain Capital’s HCA deal team. HCA is one of the nation’s leading healthcare services providers, with over 182 hospitals and 2,300 sites of care in 20 states and the United Kingdom. Its origins date back to 1968 when it was one of the first hospital companies in the United States. Our conversation covers HCA’s history, the private equity environment in the mid-2000s, and the impetus for the HCA buyout. We discuss the complexity of navigating a large-scale transaction, conducting due diligence discretely, navigating the financial crisis, and what happened to the company. We turn to HCA’s return to the public markets through an IPO in 2011, Bain Capital’s eventual exit of the investment, and the implications of the deal on the firm and industry. For full show notes, visit the episode webpage here. Learn More Follow Ted on Twitter at @tseides or LinkedIn Subscribe to the mailing list Access Transcript with Premium Membership